Cargando…
Apelin/APJ system: A key therapeutic target for liver disease
Apelin, a new bioactive peptide, was identified as an endogenous ligand for APJ (Angiotensin II receptor-like 1). Apelin and its receptor have an abundant distribution in central nervous system and peripheral tissues, including liver. Apelin/APJ has diverse physiological and pathological effects, in...
Autores principales: | Lv, Shuang-Yu, Cui, Binbin, Chen, Wei-Dong, Wang, Yan-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762386/ https://www.ncbi.nlm.nih.gov/pubmed/29340118 http://dx.doi.org/10.18632/oncotarget.22841 |
Ejemplares similares
-
The Apelin/APJ System in Psychosis and Neuropathy
por: Lv, Shuang-Yu, et al.
Publicado: (2020) -
The Role of the Apelin/APJ System in the Regulation of Liver Disease
por: Lv, Xinrui, et al.
Publicado: (2017) -
Apelin/APJ system: an emerging therapeutic target for neurological diseases
por: Li, Ao, et al.
Publicado: (2022) -
Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system
por: Liu, Wei, et al.
Publicado: (2020) -
The Apelin-APJ System in the Evolution of Heart Failure
por: GOIDESCU, CERASELA MIHAELA, et al.
Publicado: (2015)